140 related articles for article (PubMed ID: 38447738)
1. Incidence and Prediction of Unrelated Mortality After Successful Endoscopic Eradication Therapy for Barrett's Neoplasia.
van Munster SN; Verheij EPD; Ozdemir Ö; Toes-Zoutendijk E; Lansdorp-Vogelaar I; Nieuwenhuis EA; Cotton CC; Weusten BLAM; Alvarez Herrero L; Alkhalaf A; Schenk BE; Schoon EJ; Curvers WL; Koch AD; de Jonge PF; Tang TJ; Nagengast WB; Westerhof J; Houben MHMG; Shaheen NJ; Bergman JJGHM; Pouw RE
Gastroenterology; 2024 Jun; 166(6):1058-1068. PubMed ID: 38447738
[TBL] [Abstract][Full Text] [Related]
2. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy.
Smith ZL; Thorgerson AM; Dawson AZ; Wani S
Dig Dis Sci; 2023 Dec; 68(12):4439-4448. PubMed ID: 37863992
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus.
Wolf WA; Pasricha S; Cotton C; Li N; Triadafilopoulos G; Muthusamy VR; Chmielewski GW; Corbett FS; Camara DS; Lightdale CJ; Wolfsen H; Chang KJ; Overholt BF; Pruitt RE; Ertan A; Komanduri S; Infantolino A; Rothstein RI; Shaheen NJ
Gastroenterology; 2015 Dec; 149(7):1752-1761.e1. PubMed ID: 26327132
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes after endoscopic treatment for Barrett's neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period.
van Munster S; Nieuwenhuis E; Weusten BLAM; Alvarez Herrero L; Bogte A; Alkhalaf A; Schenk BE; Schoon EJ; Curvers W; Koch AD; van de Ven SEM; de Jonge PJF; Tang TJ; Nagengast WB; Peters FTM; Westerhof J; Houben MHMG; Bergman JJ; Pouw RE;
Gut; 2022 Feb; 71(2):265-276. PubMed ID: 33753417
[TBL] [Abstract][Full Text] [Related]
7. AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia.
Rubenstein JH; Sawas T; Wani S; Eluri S; Singh S; Chandar AK; Perumpail RB; Inadomi JM; Thrift AP; Piscoya A; Sultan S; Singh S; Katzka D; Davitkov P
Gastroenterology; 2024 Jun; 166(6):1020-1055. PubMed ID: 38763697
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic Resection Without Subsequent Ablation Therapy for Early Barrett's Neoplasia: Endoscopic Findings and Long-Term Mortality.
van Munster SN; Nieuwenhuis EA; Weusten BLAM; Herrero LA; Bogte A; Alkhalaf A; Schenk BE; Schoon EJ; Curvers W; Koch AD; van de Ven SEM; de Jonge PJF; Tang T; Nagengast WB; Peters FTM; Westerhof J; Houben MHMG; Bergman JJGHM; Pouw RE;
J Gastrointest Surg; 2021 Jan; 25(1):67-76. PubMed ID: 33140322
[TBL] [Abstract][Full Text] [Related]
9. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.
Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD
Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study.
Verbeek RE; Leenders M; Ten Kate FJ; van Hillegersberg R; Vleggaar FP; van Baal JW; van Oijen MG; Siersema PD
Am J Gastroenterol; 2014 Aug; 109(8):1215-22. PubMed ID: 24980881
[TBL] [Abstract][Full Text] [Related]
11. Surveillance and follow-up strategies in patients with high-grade dysplasia in Barrett's esophagus: a Dutch population-based study.
Verbeek RE; van Oijen MG; ten Kate FJ; Vleggaar FP; Schipper ME; Casparie MK; van Baal JW; Siersema PD
Am J Gastroenterol; 2012 Apr; 107(4):534-42. PubMed ID: 22270082
[TBL] [Abstract][Full Text] [Related]
12. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
[TBL] [Abstract][Full Text] [Related]
15. Mortality in Barrett's esophagus: three decades of experience at a single center.
Caygill CP; Royston C; Charlett A; Wall CM; Gatenby PA; Ramus JR; Watson A; Winslet M; Bardhan KD
Endoscopy; 2012 Oct; 44(10):892-8. PubMed ID: 22752886
[TBL] [Abstract][Full Text] [Related]
16. Dysplastic Recurrence After Successful Treatment for Early Barrett's Neoplasia: Development and Validation of a Prediction Model.
van Munster SN; Nieuwenhuis E; Bisschops R; Willekens H; Weusten BLAM; Herrero LA; Bogte A; Alkhalaf A; Schenk EBE; Schoon EJ; Curvers W; Koch AD; de Jonge PJF; Tang TJ; Nagengast WB; Westerhof J; Houben MHMG; Seewald S; Eijkemans MJC; Bergman JJGHM; Pouw RE
Gastroenterology; 2022 Jul; 163(1):285-294. PubMed ID: 35306024
[TBL] [Abstract][Full Text] [Related]
17. Treatment Outcomes of Endoscopic Submucosal Dissection for Adenocarcinoma Originating from Long-Segment Barrett's Esophagus versus Short-Segment Barrett's Esophagus.
Shimizu T; Fujisaki J; Omae M; Yamasaki A; Horiuchi Y; Ishiyama A; Yoshio T; Hirasawa T; Yamamoto Y; Tsuchida T
Digestion; 2018; 97(4):316-323. PubMed ID: 29539629
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study.
Wani S; Abrams J; Edmundowicz SA; Gaddam S; Hovis CE; Green D; Gupta N; Higbee A; Bansal A; Rastogi A; Early D; Lightdale CJ; Sharma P
Dig Dis Sci; 2013 Jun; 58(6):1703-9. PubMed ID: 23633158
[TBL] [Abstract][Full Text] [Related]
20. Complete Barrett's excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture.
Chung A; Bourke MJ; Hourigan LF; Lim G; Moss A; Williams SJ; McLeod D; Fanning S; Kariyawasam V; Byth K
Endoscopy; 2011 Dec; 43(12):1025-32. PubMed ID: 22068701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
